Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12 EUR | 0.00% | -2.04% | -5.88% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Sales 2024 * | 8.15M 8.69M | Sales 2025 * | 11.95M 12.75M | Capitalization | 336M 358M |
---|---|---|---|---|---|
Net income 2024 * | -14M -14.93M | Net income 2025 * | -18M -19.2M | EV / Sales 2024 * | 39.8 x |
Net cash position 2024 * | 11.6M 12.37M | Net Debt 2025 * | 7M 7.47M | EV / Sales 2025 * | 28.7 x |
P/E ratio 2024 * |
-24
x | P/E ratio 2025 * |
-18.3
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.38% |
Latest transcript on Hyloris Pharmaceuticals SA
1 week | -1.64% | ||
Current month | +4.80% | ||
1 month | +1.69% | ||
3 months | -7.69% | ||
6 months | -2.83% | ||
Current year | -5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jacobsen
FOU | Founder | 50 | 11-12-31 |
Stijn van Rompay
FOU | Founder | 48 | 11-12-31 |
Director of Finance/CFO | 53 | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carolyn Myers
BRD | Director/Board Member | 66 | 19-12-31 |
James Gale
BRD | Director/Board Member | 74 | 19-12-31 |
Leon van Rompay
BRD | Director/Board Member | 75 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 12 | 0.00% | 14 706 |
24-04-18 | 12 | +0.42% | 5,421 |
24-04-17 | 11.95 | -0.42% | 9,595 |
24-04-16 | 12 | -2.44% | 17,979 |
24-04-15 | 12.3 | +0.82% | 10,123 |
Real-time Euronext Bruxelles, April 19, 2024 at 09:07 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.88% | 358M | |
+27.97% | 672B | |
+23.81% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.36% | 211B | |
-0.35% | 203B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- HYL Stock